Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro - Research and Markets

Research and Markets
Posted on: 17 Nov 16

Research and Markets has announced the addition of the "US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro" report to their offering.

Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost.

The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period. Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM).

Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.

Key Topics Covered:

Table Of Contents I

List Of Figures Iii

List Of Charts Iv

Executive Summary

U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

Research Methodology

Companies Mentioned


Novo Nordisk

Eli Lilly


Johnson & Johnson

Becton Dickinson






Trividia Health


Nova Biomedical


For more information about this report visit

View source version on

Business Wire

Last updated on: 17/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.